Sterling Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Sterling Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.7K	Sell	1,278 -946	-43%	-$32.9K	﹤0.01%	1548
2025 Q4	$67.4K	Buy	2,224 +347	+18%	+$9.67K	﹤0.01%	1684
2025 Q3	$36.1K	Buy	1,877 +1,143	+156%	+$16.9K	﹤0.01%	1879
2025 Q2	$8.23K	Buy	+734	New	+$7.65K	﹤0.01%	2253

Other funds holding ORKA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return